Everolimus-Based Immunosuppression in Liver Transplant Recipients

被引：2
|
作者：
Saliba, F. [1 ]
机构：
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, INSERM,Unite 1193, Villejuif, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷 / 09期
关键词：
D O I：
10.1111/ajt.14388
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：2489 / 2489
页数：1
相关论文
共 50 条
  • [21] THE CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS AMELIORATES RENAL FUNCTION AND PREVENTS HEPATOCELLULAR CARCINOMA WITHOUT ANY EPISODE OF REJECTION
    Cholongitas, E.
    Theocharidou, E.
    Antoniadis, N.
    Goulis, J.
    Fouzas, J.
    Imvrios, G.
    Giouleme, O.
    Akriviadis, E.
    Papanikolaou, V.
    Vasiliadis, T.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S65 - S65
  • [22] Pregnancy under everolimus-based immunosuppression
    Veroux, Massimiliano
    Corona, Daniela
    Veroux, Pierfrancesco
    TRANSPLANT INTERNATIONAL, 2011, 24 (12) : E115 - E117
  • [23] Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
    Wujcik, K.
    Barkoff, L.
    Lee, J.
    Hollander, S. A.
    Chen, C.
    Gonzales, S.
    Profita, E.
    Almond, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S623 - S624
  • [24] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    TRANSPLANTATION, 2014, 98 : 804 - 805
  • [25] Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    Experimental and Clinical Transplantation, 2016, 14 (04) : 361 - 366
  • [26] A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
    Chadban, Steven J.
    Eris, Josette Marie
    Kanellis, John
    Pilmore, Helen
    Lee, Po Chang
    Lim, Soo Kun
    Woodcock, Chad
    Kurstjens, Nicol
    Russ, Graeme
    TRANSPLANT INTERNATIONAL, 2014, 27 (03) : 302 - 311
  • [27] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study.
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 804 - 805
  • [28] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression
    Peddi, V. Ram
    Marder, Bradley
    Gaite, Luis
    Oberholzer, Jose
    Goldberg, Ryan
    Pearson, Thomas
    Yang, Harold
    Allamassey, Lisa
    Polinsky, Martin
    Formica, Richard N.
    TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
  • [29] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [30] Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept plus Everolimus-Based Immunosuppression
    Peddi, V. R.
    Marder, B.
    Gaite, L.
    Oberholzer, J.
    Goldberg, R.
    Pearson, T.
    Yang, H.
    Allamassey, L.
    Gao, S.
    Polinsky, M.
    Formica, R. N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 922 - 922
12345